{"id":1542,"date":"2021-09-17T16:22:21","date_gmt":"2021-09-17T14:22:21","guid":{"rendered":"https:\/\/www.gpbullhound.com\/article\/definitive-healthcare\/"},"modified":"2021-09-17T16:22:21","modified_gmt":"2021-09-17T14:22:21","slug":"definitive-healthcare","status":"publish","type":"article","link":"https:\/\/www.gpbullhound.com\/articles\/definitive-healthcare\/","title":{"rendered":"Transforming data into healthcare intelligence."},"content":{"rendered":"\n
In a world where healthcare is more complex, global and urgent than ever, there is a clear need to improve efficiency throughout the ecosystem. Definitive Healthcare is a crucial part of solving this need with their cloud-based intelligence platform. Whether you want to increase your sales, develop marketing campaigns or find experts for clinical trials, Definitive\u2019s platform will help you.<\/p>\n\n\n\n
GP Bullhound Fund IV became a shareholder in Definitive Healthcare when they acquired Monocl, the leading subscription-based provider of medical and scientific expert data and insights. GP Bullhound Fund IV invested in Monocl in 2019 and has been an active shareholder ever since, as a member of the board, supporting the company through its internationalisation and strategic choices.<\/p>\n\n\n\n
Joakim Dal, Partner at GP Bullhound, commented: \u201cThe whole healthcare industry is working in a more data-driven way. Definitive, and of course Monocl which we invested in originally, are leading this change. I would like to congratulate Jason Krantz, Bj\u00f6rn Carlsson, and the rest of the team for this successful milestone. We are proud to be shareholders in this exceptional business.\u201d<\/p>\n\n\n\n